Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Neoleukin Therapeutics Inc (NLTX)

Neoleukin Therapeutics Inc (NLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, CCF, SCU, NLTX PR Newswire - Tue Aug 22, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HCCI : 45.51 (+0.09%)
CCF : 127.49 (+0.04%)
SCU : 12.72 (-0.24%)
NLTX : 13.96 (+1.45%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU PR Newswire - Tue Aug 15, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PRDS : 2.16 (unch)
CCF : 127.49 (+0.04%)
NLTX : 13.96 (+1.45%)
SCU : 12.72 (-0.24%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, CCF, NLTX, SCU PR Newswire - Mon Aug 7, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMNB : 47.76 (-0.33%)
CCF : 127.49 (+0.04%)
NLTX : 13.96 (+1.45%)
SCU : 12.72 (-0.24%)
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm PR Newswire - Thu Aug 3, 2023

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

PRDS : 2.16 (unch)
AMNB : 47.76 (-0.33%)
NLTX : 13.96 (+1.45%)
SCU : 12.72 (-0.24%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJX, DEN, FREQ, NLTX PR Newswire - Tue Aug 1, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AJX : 3.53 (+5.06%)
DEN : 88.66 (-0.26%)
FREQ : 14.9800 (+5.94%)
NLTX : 13.96 (+1.45%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SCU : 12.72 (-0.24%)
PRDS : 2.16 (unch)
NLTX : 13.96 (+1.45%)
AJX : 3.53 (+5.06%)
Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene PR Newswire - Tue Jul 18, 2023

/PRNewswire/ -- Ademi LLP is investigating Neoleukin (Nasdaq: NLTX) for possible breaches of fiduciary duty and other violations of law in its private...

NLTX : 13.96 (+1.45%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, NLTX, FREQ PR Newswire - Tue Jul 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DEN : 88.66 (-0.26%)
NLTX : 13.96 (+1.45%)
FREQ : 14.9800 (+5.94%)
Neoleukin Therapeutics Announces Second Quarter 2022 Financial Results & Provides Corporate Update Globe Newswire - Tue Aug 9, 2022

Company to Host Conference Call Today, August 9, 2022, at 1:30 p.m. Pacific / 4:30 p.m. ...

NLTX : 13.96 (+1.45%)
Canaccord Genuity Reaffirms Their Buy Rating on Neoleukin Therapeutics (NLTX) TipRanks - Thu Jul 7, 2022

E ratio of -0.85.

NLTX : 13.96 (+1.45%)

Barchart Exclusives

5 Large-Cap Semiconductor Stocks That Outperformed Nvidia in June Barchart - 24 minutes ago
Outperforming Nvidia is quite a feat, especially for its rival large-cap semi stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot